MTI Ventures

Spectromics Limited, established in 2014 and headquartered in Manchester, UK, specializes in developing diagnostic systems to guide antibiotic treatment. The company offers a point-of-prescription test for bacterial infections, which helps healthcare professionals determine the appropriate antibiotic therapy by identifying antimicrobial susceptibility and resistance during patient appointments. This innovative approach aims to eliminate ineffective empirical prescriptions and improve patient outcomes.

Exosect Limited is a technology company based in Winchester, United Kingdom, founded in 1999 as a spin-out from the University of Southampton. The company specializes in developing innovative delivery platforms that enhance the effectiveness of pesticide formulations, addressing challenges such as pest resistance, regulatory compliance, and food chain residues. Its primary offerings include the Entostat delivery platform, which utilizes an electrostatically charged micro powder for microencapsulation and targeted release of active ingredients, and the Entomag delivery platform, a ferrous micro powder designed for the precise delivery of synthetic chemicals to control crawling insects, particularly in public health applications. With a strong portfolio of 41 patents and 28 national product registrations, Exosect is well-equipped to commercialize its patented technologies across agriculture, public health, and animal health sectors, contributing to the protection of food from pests and diseases.

Arago Technology Ltd., established in 2010 and headquartered in Manchester, UK, specializes in developing composite structure and high voltage engineering technologies for the electricity industry. The company offers consultancy services and provides electrically insulating composite cross-arms for transmission towers, enabling voltage increases without altering tower structures or heights. This innovation aims to facilitate a 50% increase in electrical energy flow by 2050, supporting decarbonization efforts and the integration of electric vehicles/heat pumps.

PowerOasis Limited is a UK-based company specializing in energy and critical infrastructure management solutions aimed at enhancing energy efficiency and infrastructure resilience. Founded in 2006 and headquartered in Swindon, the company provides an advanced Energy Management Platform, a versatile software suite that facilitates the Internet of Energy. This platform allows for the control, monitoring, and management of various energy generation, storage, and efficiency assets, tailored to meet the specific needs of its licensees, including lithium-ion battery vendors. Additionally, PowerOasis develops hybrid power systems, including a hybrid control cabinet with integrated battery compartments, SolarCompact—a solar hybrid system, and PowerCube, which houses dual generators and ancillary equipment. The company's solutions are utilized across diverse sectors, including energy storage, utilities, transportation, and oil and gas, supported by staff, agents, and distribution partners across South East Asia, Africa, the Middle East, and North America.

Oxford PV is a company based in Oxford, United Kingdom, founded in 2010 by Henry Snaith and Kevin Arthur. It specializes in the development and commercialization of thin-film perovskite solar cells, which are designed to be printed directly onto silicon solar cells, CIGS solar cells, or glass. The company's innovative technology enhances photovoltaic performance by efficiently capturing specific parts of the solar spectrum, providing a low-cost and lightweight alternative for energy generation. Oxford PV aims to contribute significantly to the growth of renewable energy globally through its advanced solar cell solutions.

Renephra Ltd., established in 2009 and headquartered in Manchester, UK, is a medical device company specializing in controlled fluid removal from the skin. Its core product employs Transdermal Fluid Removal (TFR) technology, combining micro-needles with negative pressure therapy to enable minimally invasive extraction of excess interstitial fluid. Renephra targets fluid overload and chronic oedema/lymphoedema in vascular, oncology, and other disease areas, addressing significant unmet clinical needs in an estimated £1 billion global market.

Cable-Sense Ltd is a company based in Lancaster, United Kingdom, specializing in network cabling infrastructure services. Founded in 2004, it offers a range of solutions designed to optimize and manage cabling networks for businesses. The company's technology enables real-time monitoring, scanning, and mapping of network cables, as well as providing network security and auditing services. Cable-Sense focuses on enhancing the efficiency of existing cabling systems, aiming to reduce costs related to materials, energy, and operational expenditures. By delivering comprehensive management information for each cable, Cable-Sense empowers clients to automate the planning and maintenance of their cabling infrastructure, ultimately maximizing its potential and driving significant savings.

Bioxydyn specializes in developing and applying innovative diagnostic imaging tools and services. Their portfolio focuses on enhancing the understanding of lung diseases like COPD and asthma, while also actively working on new tools for oncology and neuroscience.

Arvia Technology specializes in advanced wastewater treatment systems. Its core product is the Organics Destruction Cell (ODC), which combines adsorption and advanced oxidation to remove hard chemical oxygen demand, color, and organic micro-pollutants from water. This enables industries such as chemicals, food and beverage, pharmaceuticals, and utilities to comply with discharge regulations or reuse treated water. Arvia's technology is designed for minimal maintenance and does not produce secondary waste.

Ai2 Ltd is a biotechnology company based in Manchester, United Kingdom, established in 2004. The company specializes in the development of anti-infective peptide technology derived from the amino acid sequence of human protein Apo lipoprotein E. These peptides demonstrate broad-spectrum efficacy against various pathogens, including Gram-positive and Gram-negative bacteria, fungi, and viruses, including resistant strains. Ai2's technology has diverse applications in healthcare and personal care, encompassing ophthalmic products, oral care, advanced wound care, and medical devices. The company produces coated hydrogels, artificial joints, endotracheal tubes, wound dressings, and urinary and vascular catheters designed to prevent microbial colonization and contamination. Ai2 serves healthcare companies primarily in the United States and Europe, enabling medical practitioners to utilize its innovative technology across multiple applications.

PowerOasis Limited is a UK-based company specializing in energy and critical infrastructure management solutions aimed at enhancing energy efficiency and infrastructure resilience. Founded in 2006 and headquartered in Swindon, the company provides an advanced Energy Management Platform, a versatile software suite that facilitates the Internet of Energy. This platform allows for the control, monitoring, and management of various energy generation, storage, and efficiency assets, tailored to meet the specific needs of its licensees, including lithium-ion battery vendors. Additionally, PowerOasis develops hybrid power systems, including a hybrid control cabinet with integrated battery compartments, SolarCompact—a solar hybrid system, and PowerCube, which houses dual generators and ancillary equipment. The company's solutions are utilized across diverse sectors, including energy storage, utilities, transportation, and oil and gas, supported by staff, agents, and distribution partners across South East Asia, Africa, the Middle East, and North America.

Exosect Limited is a technology company based in Winchester, United Kingdom, founded in 1999 as a spin-out from the University of Southampton. The company specializes in developing innovative delivery platforms that enhance the effectiveness of pesticide formulations, addressing challenges such as pest resistance, regulatory compliance, and food chain residues. Its primary offerings include the Entostat delivery platform, which utilizes an electrostatically charged micro powder for microencapsulation and targeted release of active ingredients, and the Entomag delivery platform, a ferrous micro powder designed for the precise delivery of synthetic chemicals to control crawling insects, particularly in public health applications. With a strong portfolio of 41 patents and 28 national product registrations, Exosect is well-equipped to commercialize its patented technologies across agriculture, public health, and animal health sectors, contributing to the protection of food from pests and diseases.

Oxford PV is a company based in Oxford, United Kingdom, founded in 2010 by Henry Snaith and Kevin Arthur. It specializes in the development and commercialization of thin-film perovskite solar cells, which are designed to be printed directly onto silicon solar cells, CIGS solar cells, or glass. The company's innovative technology enhances photovoltaic performance by efficiently capturing specific parts of the solar spectrum, providing a low-cost and lightweight alternative for energy generation. Oxford PV aims to contribute significantly to the growth of renewable energy globally through its advanced solar cell solutions.

Eykona Medical develops and markets portable three dimensional imaging systems. Its systems are used to capture environments for videogames and in medical imaging for dermatological care. The company is based in Oxford, the United Kingdom.

Bioxydyn specializes in developing and applying innovative diagnostic imaging tools and services. Their portfolio focuses on enhancing the understanding of lung diseases like COPD and asthma, while also actively working on new tools for oncology and neuroscience.

Ai2 Ltd is a biotechnology company based in Manchester, United Kingdom, established in 2004. The company specializes in the development of anti-infective peptide technology derived from the amino acid sequence of human protein Apo lipoprotein E. These peptides demonstrate broad-spectrum efficacy against various pathogens, including Gram-positive and Gram-negative bacteria, fungi, and viruses, including resistant strains. Ai2's technology has diverse applications in healthcare and personal care, encompassing ophthalmic products, oral care, advanced wound care, and medical devices. The company produces coated hydrogels, artificial joints, endotracheal tubes, wound dressings, and urinary and vascular catheters designed to prevent microbial colonization and contamination. Ai2 serves healthcare companies primarily in the United States and Europe, enabling medical practitioners to utilize its innovative technology across multiple applications.

Exosect Limited is a technology company based in Winchester, United Kingdom, founded in 1999 as a spin-out from the University of Southampton. The company specializes in developing innovative delivery platforms that enhance the effectiveness of pesticide formulations, addressing challenges such as pest resistance, regulatory compliance, and food chain residues. Its primary offerings include the Entostat delivery platform, which utilizes an electrostatically charged micro powder for microencapsulation and targeted release of active ingredients, and the Entomag delivery platform, a ferrous micro powder designed for the precise delivery of synthetic chemicals to control crawling insects, particularly in public health applications. With a strong portfolio of 41 patents and 28 national product registrations, Exosect is well-equipped to commercialize its patented technologies across agriculture, public health, and animal health sectors, contributing to the protection of food from pests and diseases.

Nano ePrint, Ltd. develops electronic devices. Its products are used in printed and plastic electronics applications, including radio-frequency identification, sensors, and display backplanes. The company also provides intellectual property licences, as well as research, development, and supply chain support services. Nano ePrint, Ltd., formerly known as Plastic ePrint Limited, was founded in 2006. The company is based in Manchester, the United Kingdom.

Lein Applied Diagnostics Ltd. is an optical metrology company that specializes in developing measurement devices and solutions for both healthcare and industrial markets. Founded in 2003 and headquartered in Reading, United Kingdom, the company initially focused on creating a non-invasive glucose meter for diabetes care. Its core technology features a scanning confocal system capable of making precise, non-contact dimensional and structural measurements of various materials, both organic and synthetic. Lein's product lineup includes devices such as Dione, a source/detector module for multi-layer thickness measurements; Icon, a compact optical measurement system; fScan, a non-contact 3D fluorescence tracking plate reader; and CTS2, which is designed for measuring 3D engineered tissues and cells. The company's innovative measurement solutions are utilized in applications like metrology and pharmacokinetics, and are distributed through agents in key markets including China, Japan, and North America.

Datalase Ltd., based in Widnes, United Kingdom, is a leading provider of materials for laser coding and marking of products and packaging. The company specializes in developing innovative materials that can be incorporated into inks, coatings, and varnishes, enabling high-speed, in-line digital printing of variable information with lasers. This technology allows for late-stage customization on outercases, products, and primary packaging across various markets, including pharmaceuticals, FMCG, food and beverage, electronics, cosmetics, and tobacco. Datalase's solutions are used to print date and lot codes, 2-D data matrix codes, barcodes, images, and graphics. The company operates through a partner network in Europe, the United States, and Asia, and has strategic partnerships with SATO and PARC. Originally incorporated in 1987 as Sherwood Technology Ltd., the company changed its name to Datalase Ltd. in January 2006.

Eleksen Group designs and develops fabric touchpads for use in human machine interface design using its ElekTex technology. The company licenses ElekTex and reference design to manufacturers for use in custom electronics design, as well as markets a range of ready-to-integrate solutions for garment, bags, and accessories manufacturers. It offers sensors for use in soft-goods products, such as apparel and accessory products, as well as in other applications to provide control interfaces.

Global Silicon Limited, a fabless semiconductor company, engages in the design, development, and manufacture of proprietary mixed signal chips for the consumer audio market. It offers CD servo controllers and high performance MP3 and windows media audio (WMA) decoders. The company also offers PCB modules, design wins, and xin servo/mp3/wma. Global Silicon Limited was formerly known as Cheap and Cheerful Chip Company Limited. The company was incorporated in 1997 and is based in Marlow, the United Kingdom with additional offices in Fenggang, Swavesey, and Cambridge, as well as in Shenzhen, the People's Republic of China. Global Silicon Limited is in receivership.

Medisyn Technologies, Inc. is a biotechnology company based in Minnetonka, Minnesota, specializing in the development of proprietary drug compounds for various therapeutic applications, including cancer, infectious diseases, and Alzheimer's disease. Utilizing its Forward Engineering platform, the company creates pre-qualified compounds aimed at treating breast, renal, prostate, and lung cancers. Medisyn also focuses on analyzing and optimizing existing drugs while developing new candidates in collaboration with its partners. Additionally, the company provides testing and analysis services to assess the safety and efficacy of its compounds. Founded in 1999, Medisyn Technologies serves both biotech and pharmaceutical companies, facilitating quicker treatment initiation and improving the likelihood of successful outcomes for patients.

Andritz Powerlase Ltd. specializes in the design and manufacture of high-power pulsed lasers tailored for industrial applications, particularly in materials processing. Established in 2000 and located in Crawley, United Kingdom, the company provides a range of laser technologies, including infrared, green, and ultraviolet lasers. These lasers are utilized for various functions such as surface polishing, rust removal, de-painting, laser annealing, and cleaning, as well as in the processing of composite materials. Andritz Powerlase serves diverse sectors, including automotive, aerospace, and defense, by delivering innovative solutions that enhance production efficiency and meet specific industry requirements. Formerly known as Powerlase Photonics Limited, the company adopted its current name in June 2017 and operates as a subsidiary of Andritz AG.

Beach Solutions, established in 1998, specializes in providing software services tailored for the semiconductor industry. With a team possessing over 200 years of combined expertise in embedded systems engineering, the company has a strong foundation in the design of 32-bit RISC devices and systems. Its areas of proficiency include real-time systems, VHDL and RTL coding, as well as application code development in C and assembly languages. Beach Solutions also focuses on system-on-chip Internet protocol packaging, deployment, and system integration software products, catering to developers of embedded systems. The founding members of the company continue to serve on the executive board, ensuring a consistent vision and leadership.

ApaTech Ltd. is an ortho-biologics company specializing in the production of synthetic bone repair materials. Founded in 2001 and headquartered in Elstree, United Kingdom, the company offers a range of products designed to enhance bone formation and facilitate surgical procedures. Its flagship product, Actifuse, is a synthetic bone graft that promotes the formation of new bone in graft and host structures, making it suitable for small void filling and spinal fusion applications. Additionally, ApaTech provides ApaPore, a porous hydroxyapatite grafting material used for cemented revision of failed total joint arthroplasties, spinal fusions, fracture fixations, and treatment of bone defects. The Actifuse MIS Bone Graft Delivery System allows for controlled delivery and precise placement of the graft during both open and minimally invasive surgeries. ApaTech distributes its products across various countries, including those in Europe, the Middle East, and Australia, and maintains operations in London, Foxborough, Massachusetts, and Berlin, Germany.

Sarantel Group specializes in the design and manufacture of high-performance miniature antennas tailored for portable wireless applications. The company is recognized for its innovative ceramic filtering antennas, which significantly enhance performance compared to traditional designs. These antennas provide improved signal clarity and range while drastically reducing the signal radiation absorbed by the human body. Their compact size and advanced capabilities allow manufacturers to develop cutting-edge wireless products across various markets, including GPS, satellite radio, and satellite communications. Sarantel's technology positions it as a key player in the portable wireless sector, enabling advancements in connectivity and device performance.

DCT develops, licences and manufactures semiconductor IP, integrated circuits, software and development systems. Founded with personal investments from Turner & Kubiczek, it went on to win a Small Firms Merit Award for Research & Technology from the UK Department of Trade & Industry award for its novel and world-leading performance embedded Java CPU Lightfoot. Following the UK DTI investment, DCT closed two funding rounds with MTI, a global, early-stage Venture Capital investor and set up offices in California and Taiwan. DCT also developed the Bigfoot Java Accelerator IP that found application in video processor ICs. The company was incorporated in 1996 and is currently based in Egham, UK and Shanghai, China. It is presently developing an exciting new version of its Lightfoot architecture, LF v3, that will deliver new performance levels to resource-limited embedded ASSPs.

A provider of enterprise monitoring and data collection software